TY - JOUR
T1 - Detection of thyroglobulin in fine needle aspirates of nonthyroidal neck masses
T2 - A clue to the diagnosis of metastatic differentiated thyroid cancer
AU - Pacini, F.
AU - Fugazzola, L.
AU - Lippi, F.
AU - Ceccarelli, C.
AU - Centoni, R.
AU - Miccoli, P.
AU - Elisei, R.
AU - Pinchera, A.
PY - 1992
Y1 - 1992
N2 - We studied the feasibility of employing the measurement of thyroglobulin (Tg) in the washout of the needle used to perform the fine needle aspiration cytology (FNA-Tg) for the differential diagnosis of nonthyroidal neck masses of unknown etiology. We studied 35 patients presenting for 1 or more neck lumps outside the thyroid gland. A previous history of treated differentiated thyroid cancer (DTC) was given by 23 patients and of nonthyroidal malignancy by 3 patients. FNA-Tg was measured in the Tg-free serum used to wash out the needle employed for the cytology. Finally, all patients were treated by surgery. FNA-Tg was always detectable in 14 patients with thyroid cancer metastases demonstrated by histology, with a mean (± SD) of 27,087 ± 37,622 ng/FNA (P <0.002) compared to patients without thyroid cancer metastases (mean ± SD, 12.1 ± 4.8 ng/FNA in 7 cases; undetectable in 14 cases). Assuming 21.7 ng/FNA (the mean ± 2 SD of the negative patients) as the cut- off value, all patients with metastases from DTC were detected by FNA-Tg. FNA-Tg had better negative predictive value than cytology, since this last technique gave 10 inconclusive results, comprising 2 false negative results in patients with metastases from DTC. Our results indicate that elevated concentrations of FNA-Tg in nonthyroidal neck nodes strongly suggest the diagnosis of metastases from DTC.
AB - We studied the feasibility of employing the measurement of thyroglobulin (Tg) in the washout of the needle used to perform the fine needle aspiration cytology (FNA-Tg) for the differential diagnosis of nonthyroidal neck masses of unknown etiology. We studied 35 patients presenting for 1 or more neck lumps outside the thyroid gland. A previous history of treated differentiated thyroid cancer (DTC) was given by 23 patients and of nonthyroidal malignancy by 3 patients. FNA-Tg was measured in the Tg-free serum used to wash out the needle employed for the cytology. Finally, all patients were treated by surgery. FNA-Tg was always detectable in 14 patients with thyroid cancer metastases demonstrated by histology, with a mean (± SD) of 27,087 ± 37,622 ng/FNA (P <0.002) compared to patients without thyroid cancer metastases (mean ± SD, 12.1 ± 4.8 ng/FNA in 7 cases; undetectable in 14 cases). Assuming 21.7 ng/FNA (the mean ± 2 SD of the negative patients) as the cut- off value, all patients with metastases from DTC were detected by FNA-Tg. FNA-Tg had better negative predictive value than cytology, since this last technique gave 10 inconclusive results, comprising 2 false negative results in patients with metastases from DTC. Our results indicate that elevated concentrations of FNA-Tg in nonthyroidal neck nodes strongly suggest the diagnosis of metastases from DTC.
UR - http://www.scopus.com/inward/record.url?scp=0026777246&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0026777246&partnerID=8YFLogxK
U2 - 10.1210/jc.74.6.1401
DO - 10.1210/jc.74.6.1401
M3 - Article
C2 - 1592886
AN - SCOPUS:0026777246
SN - 0021-972X
VL - 74
SP - 1401
EP - 1404
JO - Journal of Clinical Endocrinology and Metabolism
JF - Journal of Clinical Endocrinology and Metabolism
IS - 6
ER -